Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$62.17 - $97.62 $161,642 - $253,812
-2,600 Reduced 10.48%
22,200 $2.17 Million
Q4 2022

Feb 08, 2023

BUY
$60.21 - $77.74 $30,105 - $38,870
500 Added 2.06%
24,800 $1.54 Million
Q3 2022

Nov 09, 2022

BUY
$72.92 - $99.73 $14,584 - $19,946
200 Added 0.83%
24,300 $1.77 Million
Q1 2022

May 09, 2022

BUY
$122.89 - $171.74 $221,202 - $309,132
1,800 Added 8.07%
24,100 $3.33 Million
Q4 2021

Feb 08, 2022

BUY
$156.0 - $265.78 $62,400 - $106,311
400 Added 1.83%
22,300 $4.07 Million
Q3 2021

Nov 08, 2021

BUY
$228.69 - $274.2 $480,249 - $575,820
2,100 Added 10.61%
21,900 $5.66 Million
Q2 2021

Aug 06, 2021

SELL
$169.89 - $231.37 $118,922 - $161,959
-700 Reduced 3.41%
19,800 $4.55 Million
Q1 2021

May 07, 2021

BUY
$143.93 - $207.3 $43,179 - $62,190
300 Added 1.49%
20,500 $3.45 Million
Q3 2020

Nov 09, 2020

BUY
$90.16 - $107.61 $324,576 - $387,396
3,600 Added 21.69%
20,200 $2 Million
Q2 2020

Aug 05, 2020

BUY
$52.17 - $95.63 $114,774 - $210,386
2,200 Added 15.28%
16,600 $1.55 Million
Q1 2020

May 08, 2020

BUY
$52.76 - $109.0 $15,828 - $32,700
300 Added 2.13%
14,400 $796,000
Q4 2019

Feb 06, 2020

BUY
$69.39 - $97.59 $13,878 - $19,518
200 Added 1.44%
14,100 $1.35 Million
Q3 2019

Nov 12, 2019

BUY
$64.17 - $84.08 $32,085 - $42,040
500 Added 3.73%
13,900 $985,000
Q2 2019

Aug 02, 2019

BUY
$70.1 - $85.17 $21,030 - $25,551
300 Added 2.29%
13,400 $1.14 Million
Q1 2019

May 10, 2019

BUY
$77.0 - $99.34 $46,200 - $59,604
600 Added 4.8%
13,100 $1.12 Million
Q2 2018

Aug 09, 2018

BUY
$74.5 - $108.91 $89,400 - $130,692
1,200 Added 10.62%
12,500 $1.3 Million
Q1 2018

May 04, 2018

BUY
$58.36 - $83.18 $40,852 - $58,226
700 Added 6.6%
11,300 $893,000
Q3 2017

Nov 03, 2017

BUY
$84.87 - $109.54 $899,622 - $1.16 Million
10,600
10,600 $934,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.